Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 322

The DOI matches its Crossref record; 96 of the 96 references it cites were found in a registry or an index.

Metabolic disturbances in obesity versus sleep apnoea: the importance of visceral obesity and insulin resistance

Open access
Vgontzas, A. N., Bixler, E. O., Chrousos, G. P.·2003·Journal of Internal Medicine

Abstract

Abstract. Vgontzas AN, Bixler EO, Chrousos GP (Penn State College of Medicine, Hershey, PA; National Institutes of Health, Bethesda, MD, USA). Metabolic disturbances in obesity versus sleep apnoea: the importance of visceral obesity and insulin resistance (Minisymposium). J Intern Med 2003; 254:–. Obstructive sleep apnoea (OSA) is a very prevalent disorder particularly amongst middle‐aged, obese men, although its existence in women as well as in lean individuals is increasingly recognized. Despite the early recognition of the strong association between OSA and obesity, and OSA and cardiovascular problems, sleep apnoea has been treated as a ‘local abnormality’ of the respiratory track rather than as a ‘systemic illness’. In 1997, we first reported that the pro‐inflammatory cytokines interleukin (IL)‐6 and tumour necrosis factor‐α (TNF α) were elevated in patients with disorders of excessive daytime sleepiness (EDS) and proposed that these cytokines were mediators of daytime sleepiness. Also, we reported a positive correlation between IL‐6 or TNF α plasma levels and the body mass index (BMI). In subsequent studies, we showed that IL‐6, TNF α, leptin and insulin levels were elevated in sleep apnoea independently of obesity and that visceral fat, was the primary parameter linked with sleep apnoea. The association of OSA with insulin resistance and diabetes type 2 has been confirmed since then in several epidemiological and clinical studies. Furthermore, our findings that women with polycystic ovary syndrome (PCOS, a condition associated with hyperandrogenism and insulin resistance) were much more likely than controls to have sleep disordered breathing (SDB) and daytime sleepiness support the pathogenetic role of insulin resistance in OSA. Other findings that support the view that sleep apnoea and sleepiness may be manifestations of a serious metabolic disorder, namely the Metabolic or Visceral Obesity Syndrome, include: obesity without sleep apnoea is associated with daytime sleepiness; PCOS and diabetes type 2 are independently associated with EDS after controlling for SDB, obesity and age; and increased prevalence of sleep apnoea in postmenopausal women, with hormonal replacement therapy associated with a significantly reduced risk for OSA. In conclusion, accumulating evidence provides support to our model of the bi‐directional, feedforward, pernicious association between sleep apnoea, sleepiness, inflammation and insulin resistance, all promoting atherosclerosis and cardiovascular disease.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1046/j.1365-2796.2003.01177.x

Cites

96 of 96 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 96 references

Cited by

See all 322

Metadata

Authors
Vgontzas, A. N., Bixler, E. O., & Chrousos, G. P.
Venue
Journal of Internal Medicine
Publisher
Wiley
Published
2003-06-16
Volume
254
Issue
1
Pages
32-44
ISSN
  • 0954-6820 (ISSN-L)
  • 1365-2796
OpenAlex
W1975324052
Cited by
322
References
96
FWCI
12.12
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Metabolic disturbances in obesity versus sleep apnoea: the importance of visceral obesity and insulin resistance. https://app.cochat.ai/papers/10.1046/j.1365-2796.2003.01177.x
The paper
Vgontzas, A. N., Bixler, E. O., & Chrousos, G. P. (2003). Metabolic disturbances in obesity versus sleep apnoea: the importance of visceral obesity and insulin resistance. Journal of Internal Medicine. https://doi.org/10.1046/j.1365-2796.2003.01177.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.